Literature DB >> 19633817

Renal expression of arachidonic acid metabolizing enzymes and RhoA/Rho kinases in fructose insulin resistant hypertensive rats.

Sally Mustafa1, Harish Vasudevan, Violet G Yuen, John H McNeill.   

Abstract

Fructose feeding has been shown to induce insulin resistance and hypertension. Renal protein expression for the cytochrome P (CYP) 450 arachidonic acid metabolizing enzymes has been shown to be altered in other models of diet-induced hypertension. Of special interest is CYP4A, which produces the potent vasoconstrictor, 20-hydroxyeicosatetraenoic acid and CYP2C, which catalyzes the formation of the potent dilators epoxyeicosatrienoic acids as well as soluble epoxide hydrolase (sEH) which metabolizes the latter to dihydroxyeicosatrienoic acids. The RhoA/Rho kinase (ROCK) signaling pathway is downstream of arachidonic acid and is reported to mediate metabolic-cardio-renal dysfunctions in some experimental models of insulin resistance and diabetes. The aim of the present study was to determine the expression of CYP4A, CYP2C23, CYP2C11, sEH, RhoA, ROCK-1, ROCK-2, and phospho-Lin-11/Isl-1/Mec-3 kinase (LIMK) in kidneys of fructose-fed (F) rats. Male Wistar rats were fed a high fructose diet for 8 weeks. Body weight, systolic blood pressure, insulin sensitivity, and renal expression of the aforementioned proteins were assessed. No change was observed in the body weight of F rats; however, euglycemia and hyperinsulinemia implicating impaired glucose tolerance and significant elevation in systolic blood pressure were observed. Renal expression of CYP4A and CYP2C23 was significantly increased while that of CYP2C11 and sEH was not changed in F rats. Equal expression for RhoA in both control and F rats and an enhanced level of ROCK-1 and ROCK-2 constitutively activate 130 kDa cleavage fragments as well as phospho-LIMK. These data suggest that the kidneys could be actively participating in the pathogenesis of insulin resistance-induced hypertension through the arachidonic acid CYP 450-RhoA/Rho kinase pathway(s).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633817     DOI: 10.1007/s11010-009-0220-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.

Authors:  D Galipeau; E Arikawa; I Sekirov; J H McNeill
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Effects of fructose loading in streptozotocin-diabetic and nondiabetic rats.

Authors:  S Dai; J H McNeill
Journal:  Can J Physiol Pharmacol       Date:  1992-12       Impact factor: 2.273

3.  ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice.

Authors:  O Nakagawa; K Fujisawa; T Ishizaki; Y Saito; K Nakao; S Narumiya
Journal:  FEBS Lett       Date:  1996-08-26       Impact factor: 4.124

4.  The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading.

Authors:  V R Holla; K Makita; P G Zaphiropoulos; J H Capdevila
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

5.  Fructose-induced insulin resistance and hypertension in rats.

Authors:  I S Hwang; H Ho; B B Hoffman; G M Reaven
Journal:  Hypertension       Date:  1987-11       Impact factor: 10.190

6.  Increased RhoA translocation in renal cortex of diabetic rats.

Authors:  Amber R Massey; Liyang Miao; Brandi N Smith; Jiankang Liu; Ikuyo Kusaka; John H Zhang; Jiping Tang
Journal:  Life Sci       Date:  2003-05-16       Impact factor: 5.037

Review 7.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 8.  Redefining type 2 diabetes: 'diabesity' or 'obesity dependent diabetes mellitus'?

Authors:  A Astrup; N Finer
Journal:  Obes Rev       Date:  2000-10       Impact factor: 9.213

9.  Rho-associated kinase of chicken gizzard smooth muscle.

Authors:  J Feng; M Ito; Y Kureishi; K Ichikawa; M Amano; N Isaka; K Okawa; A Iwamatsu; K Kaibuchi; D J Hartshorne; T Nakano
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

10.  Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.

Authors:  Vasantha Kolavennu; Lixia Zeng; Hui Peng; Yin Wang; Farhad R Danesh
Journal:  Diabetes       Date:  2007-12-14       Impact factor: 9.461

View more
  3 in total

Review 1.  Potential benefits of rho-kinase inhibition in arterial hypertension.

Authors:  Olaf Grisk
Journal:  Curr Hypertens Rep       Date:  2013-10       Impact factor: 5.369

2.  Significance of serum Zn-α2-glycoprotein for the regulation of blood pressure.

Authors:  Souichi Kurita; Keisuke Takeuchi; Yoshimi Hayashi; Hisao Ueyama; Dimitar P Zankov; Xiaoling Pang; Takanobu Otsuka; Iwao Ohkubo; Osamu Ogikubo; Hisakazu Ogita
Journal:  Hypertens Res       Date:  2014-11-27       Impact factor: 3.872

Review 3.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.